| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Ets_dom | 2.16e-10 | 28 | 24 | 5 | IPR000418 | |
| Domain | Ets | 2.16e-10 | 28 | 24 | 5 | PF00178 | |
| Domain | ETS_DOMAIN_1 | 2.16e-10 | 28 | 24 | 5 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 2.16e-10 | 28 | 24 | 5 | PS00346 | |
| Domain | ETS_DOMAIN_3 | 2.16e-10 | 28 | 24 | 5 | PS50061 | |
| Domain | ETS | 2.16e-10 | 28 | 24 | 5 | SM00413 | |
| Domain | - | 2.67e-07 | 218 | 24 | 6 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 4.92e-07 | 242 | 24 | 6 | IPR011991 | |
| Domain | ETV3 | 1.58e-06 | 2 | 24 | 2 | IPR032929 | |
| Domain | IQ | 3.73e-03 | 71 | 24 | 2 | PF00612 | |
| Domain | IQ | 4.82e-03 | 81 | 24 | 2 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 5.92e-03 | 90 | 24 | 2 | IPR000048 | |
| Domain | IQ | 6.30e-03 | 93 | 24 | 2 | PS50096 | |
| Domain | - | 8.12e-03 | 106 | 24 | 2 | 1.10.150.50 | |
| Domain | SAM/pointed | 9.81e-03 | 117 | 24 | 2 | IPR013761 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 1.63e-04 | 16 | 17 | 2 | MM14903 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 1.84e-04 | 17 | 17 | 2 | M14449 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 1.84e-04 | 17 | 17 | 2 | MM1435 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 3.80e-04 | 299 | 17 | 4 | M41727 | |
| Pubmed | 5.75e-09 | 29 | 26 | 4 | 17907201 | ||
| Pubmed | 5.75e-09 | 29 | 26 | 4 | 26097038 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 10913304 | ||
| Pubmed | ETS-dependent regulation of a distal Gata4 cardiac enhancer. | 7.43e-07 | 24 | 26 | 3 | 22056786 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18172009 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 23117818 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 29118074 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 28380351 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 11313879 | ||
| Pubmed | Differential repression of c-myc and cdc2 gene expression by ERF and PE-1/METS. | 8.05e-06 | 6 | 26 | 2 | 17525531 | |
| Pubmed | Androgen upregulates NR4A1 via the TFAP2A and ETS signaling networks. | 1.13e-05 | 7 | 26 | 2 | 31146003 | |
| Pubmed | Association between IFNA genotype and the risk of sarcoidosis. | 2.94e-05 | 11 | 26 | 2 | 15004750 | |
| Pubmed | 4.86e-05 | 14 | 26 | 2 | 18715339 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 6.33e-05 | 1425 | 26 | 7 | 30948266 | |
| Pubmed | 6.44e-05 | 1429 | 26 | 7 | 35140242 | ||
| Pubmed | 4.33e-04 | 41 | 26 | 2 | 18951430 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.89e-04 | 1192 | 26 | 5 | chr19q13 | |
| GeneFamily | ETS transcription factor family | 5.16e-11 | 28 | 18 | 5 | 534 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.75e-02 | 206 | 18 | 2 | 682 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-T_reg|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.84e-06 | 196 | 26 | 4 | 6362fb0b5dc923f19a76b605d7289a16f89220e3 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 5.04e-06 | 198 | 26 | 4 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.58e-05 | 148 | 26 | 3 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 157 | 26 | 3 | 2c767c526abcc8adea6ec4eb2cc333060bb213b5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T4|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.04e-04 | 158 | 26 | 3 | 53afcc8132cd61bae1adbdedb83e5bac6690bc8d | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 162 | 26 | 3 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 164 | 26 | 3 | 22f37c39fdce2cf6dc72c6db619537d4b0234839 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.20e-04 | 166 | 26 | 3 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 166 | 26 | 3 | fb2cfbf1d0a0f1950dd24c08ba00ebd64b06ceb4 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.27e-04 | 169 | 26 | 3 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12-45|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 170 | 26 | 3 | e028e22ad051c2628248b212b5d28b891e0ee782 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 170 | 26 | 3 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 171 | 26 | 3 | 656a9f407461dbf5c9c0bd234399e1fef6abce2a | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.32e-04 | 171 | 26 | 3 | ce290930385cac35dbd21a5e91cf0f93cf3e99f8 | |
| ToppCell | droplet-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 26 | 3 | f6c00a6a7e81aaf96c55eb3a3c88e3719f102ea0 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 172 | 26 | 3 | f3bbe3f069ad070778430d1a6cd9db0a76deb8de | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 172 | 26 | 3 | 3784fd1e833703519889942e39fda991f03c3c76 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 26 | 3 | 7af0713c40ea48f1e92c859c4fc4d8f0137c4415 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 172 | 26 | 3 | 995139aa38f8b9ff23166128b15476cd8a3ff1b8 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 174 | 26 | 3 | 7ebf06076946729c1af25109df6066731097c3b1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 174 | 26 | 3 | 90961e8839514985712b8b986aec3391bb249ba7 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 174 | 26 | 3 | c4b0987d9394f977fe6bc6a4214a6d8d73d0abcc | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 175 | 26 | 3 | 738b3d476ac494e2e79b70b3b83bc1b7ae8396bd | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-MAIT|Lung / Manually curated celltypes from each tissue | 1.41e-04 | 175 | 26 | 3 | f6663e5a9c87e27f3459a6481768b03aff7d0855 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 177 | 26 | 3 | a58c93be9767e3fe8fbb6b0db1210d3a33aac662 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 177 | 26 | 3 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 177 | 26 | 3 | 3ed383e5c0b15d9d5e75b98cf6d10609f48fc422 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like|Lung / Manually curated celltypes from each tissue | 1.48e-04 | 178 | 26 | 3 | bb5dc22f6bcde1ce29598ae4e839e98a7caa07b6 | |
| ToppCell | BL-critical-LOC-Lymphoid-NKT|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.56e-04 | 181 | 26 | 3 | e3add2412c9f8eddfb77e0fbcd66fe57b23ae513 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 182 | 26 | 3 | 09d0793245d3d77ab5fc384c0b62637f736da50b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 183 | 26 | 3 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 183 | 26 | 3 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | 8383ac2ddaca24ca2ffae457c4e9c5cd8739b2cf | |
| ToppCell | droplet-Kidney-nan-24m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | aff47614fe095a59697b0cde301f1b4aad1b1c9c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 186 | 26 | 3 | c0a58e43a813441d3a1708236737b15db8bea10e | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | 1ba8de194220b69ece8b33c00e9ad278f513ed6a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 186 | 26 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-04 | 187 | 26 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Lymphocytic-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | 16b2fddf2c23a29f173102f117876c9df5544ae4 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 13e72b0a2b62d95c805294645fca79d8f96e9e78 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 188 | 26 | 3 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.74e-04 | 188 | 26 | 3 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 189 | 26 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 1.79e-04 | 190 | 26 | 3 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Severe-Lymphoid-T-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.79e-04 | 190 | 26 | 3 | 60642de433f84fa2cecd796c3a1a4aab9219d3db | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 191 | 26 | 3 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 191 | 26 | 3 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 191 | 26 | 3 | e5c41c3054ead03597c136eaccaf9822e6bb9d1a | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 191 | 26 | 3 | 7e24175c7fabe5ea0b22b73173da4c3a666e5eb8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-04 | 191 | 26 | 3 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-04 | 192 | 26 | 3 | 453c11f468117ffdd8c248fee1e5bb1f5401cc33 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | bf0819e99d7bf742c33afad2a0b66a60e1cfb1c2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 192 | 26 | 3 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Lymphocytic|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | e1f917250478805db84a74570272b2f106993e29 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.88e-04 | 193 | 26 | 3 | 4773a493c7607d9c7fe0342080b53f0a23420ce9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-04 | 193 | 26 | 3 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-04 | 193 | 26 | 3 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.91e-04 | 194 | 26 | 3 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_EM_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.94e-04 | 195 | 26 | 3 | 4b8831ed8fb73579f49604eeda8a3b2344e69f0e | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.97e-04 | 196 | 26 | 3 | 1b06639b7d2b81a1e5bcc455f3adda039f42ba57 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, condition lineage and cell class | 2.00e-04 | 197 | 26 | 3 | 8f35f9741086a38f0e594dce0547b575946f52bb | |
| ToppCell | control-Lymphocytic-CD4_T_cells_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.00e-04 | 197 | 26 | 3 | bd2a64bee89e0fff1c72557dc7da18474a784005 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.03e-04 | 198 | 26 | 3 | 6ccdcce20bf48ab4bd91de6b65f2832c34bc3978 | |
| ToppCell | severe-Lymphocytic|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.03e-04 | 198 | 26 | 3 | 7b85f763a5f5fb7bed8e0d702364a2dd18a74f7d | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.03e-04 | 198 | 26 | 3 | ed177a75c2a550b2394115777b70d86da4c9c845 | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.03e-04 | 198 | 26 | 3 | 2ae52051f7aeaaa4fc739914ac396ba49eaa525d | |
| ToppCell | mild-Lymphocytic|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.06e-04 | 199 | 26 | 3 | 57a429b4c98decbd0bffb67733eaae1f907898a3 | |
| ToppCell | control-Lymphocytic|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.06e-04 | 199 | 26 | 3 | 3437cb814d00758109c4af37f30e0f9088e94147 | |
| ToppCell | NS-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.06e-04 | 199 | 26 | 3 | e2d0346cc0c45253b1f958e11263f45e09fd38cb | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 199 | 26 | 3 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | Severe-Lymphoid|Severe / Condition, Lineage, Cell class and cell subclass | 2.06e-04 | 199 | 26 | 3 | 928e346b0f31d991ebab12fefb4eb9f4249e601d | |
| ToppCell | Severe-Lymphoid-T|Severe / Condition, Lineage, Cell class and cell subclass | 2.06e-04 | 199 | 26 | 3 | ad2be3739721b7bfc2bd50eafd01d4325b01016e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.09e-04 | 200 | 26 | 3 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefh_(Cerebellum_basket_cells_1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.42e-04 | 47 | 26 | 2 | 59811807a4b5baec55505bb4c38ac684b0a49c9a | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefh_(Cerebellum_basket_cells_1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.42e-04 | 47 | 26 | 2 | 74ed0dc55bcfe6e5f7bab42ee060692d51a39e5a | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.06e-03 | 83 | 26 | 2 | 3aa95bf2d8ac37e648037faf3d54ebb243a4fde1 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.06e-03 | 83 | 26 | 2 | 70804dd63221dd5ed26068ec1b50f11875abbc50 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.06e-03 | 83 | 26 | 2 | c1818411438f53aec76afead5c8caab701b95d39 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.06e-03 | 83 | 26 | 2 | 1e7af8aaa20b4c2a77cf2f330113db0faa9d483c | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.45e-03 | 97 | 26 | 2 | 1da964954a95c497ac4a24df1ea3575df5747025 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.45e-03 | 97 | 26 | 2 | dd188763ba02337e4f25d56766eda886cffa810d | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.45e-03 | 97 | 26 | 2 | a0242258aad0766450ff52fe28278cbb2b8d63a0 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.45e-03 | 97 | 26 | 2 | 98a31b9bf0adcad1cb1d803bf7a23d49b4e1f2d5 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-03 | 102 | 26 | 2 | 30fa92383898f370dabc41dd23d6907f14ba1a06 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-03 | 102 | 26 | 2 | c58e09aaa11b664c7d99e91f903561fa18460f05 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-03 | 102 | 26 | 2 | 9392288e284b71f3a208d9f283e6e3c944b7dd10 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-03 | 102 | 26 | 2 | 57ad3d48adeb41f6ab65883e61d3b1e74a94ad1a | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-03 | 102 | 26 | 2 | 0ec549ee94da5f2d7275490e90d816c645f6d4fc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.92e-03 | 112 | 26 | 2 | 3a215149dc13d4619e701ed55799e24b1b7bd4d9 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-03 | 125 | 26 | 2 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | LPS_only-Endothelial-Epi-like|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-03 | 126 | 26 | 2 | 4c598f7bae09aca7a4ecce63dfd6890b26468c73 | |
| Drug | NSC626122 | 3.47e-06 | 3 | 25 | 2 | CID000362378 | |
| Drug | AC1L9IIO | 3.47e-06 | 3 | 25 | 2 | CID000445749 | |
| Drug | N-(2-hydroxyethyl)phenazinium | 6.94e-06 | 4 | 25 | 2 | CID000125436 | |
| Drug | AC1LCW0P | 2.42e-05 | 7 | 25 | 2 | CID000657096 | |
| Disease | Malignant neoplasm of salivary gland | 7.22e-04 | 45 | 26 | 2 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 7.88e-04 | 47 | 26 | 2 | C0036095 | |
| Disease | complement factor H-related protein 4 measurement | 8.56e-04 | 49 | 26 | 2 | EFO_0600091 | |
| Disease | multiple sclerosis | 1.71e-03 | 594 | 26 | 4 | MONDO_0005301 | |
| Disease | Adenoid Cystic Carcinoma | 3.50e-03 | 100 | 26 | 2 | C0010606 | |
| Disease | primary biliary cirrhosis | 6.11e-03 | 133 | 26 | 2 | EFO_1001486 | |
| Disease | inflammatory bowel disease | 7.02e-03 | 449 | 26 | 3 | EFO_0003767 | |
| Disease | total blood protein measurement | 7.02e-03 | 449 | 26 | 3 | EFO_0004536 | |
| Disease | lymphocyte count | 8.21e-03 | 1464 | 26 | 5 | EFO_0004587 | |
| Disease | Alzheimer disease | 8.66e-03 | 485 | 26 | 3 | MONDO_0004975 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 9.79e-03 | 170 | 26 | 2 | EFO_0000685, EFO_0007791, EFO_0007837 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSRALRYYYNKRILH | 96 | A0A1W2PQ73 | |
| LSRALRYYYNKRILH | 81 | P50548 | |
| SRALRYYYDKNIIRK | 61 | P19419 | |
| SRALRYYYNKRILHK | 91 | P41162 | |
| QRKVDYVLAYHYRKR | 96 | Q9NQ90 | |
| YYHLNAVRIQRAYKL | 3116 | Q8IZT6 | |
| LYRVYKEVKNRLDYH | 186 | P24539 | |
| RKRYGYRLDYHEKKR | 11 | O95478 | |
| RYIYYLITKKRASHK | 76 | Q9Y530 | |
| HRKFQGYYKIARHYR | 176 | P26572 | |
| RYTSRFYLKFKHLER | 221 | Q68DU8 | |
| HYSRRNKLILYKFDR | 61 | Q99665 | |
| ERHYRKSYLKRKYLL | 146 | Q9NX04 | |
| RGLRYYYDKNIIHKT | 391 | P14921 | |
| HYKVCYARVLDYRRK | 186 | Q9BT78 | |
| SKYLIYRRYRQFHAL | 51 | Q15080 | |
| LHLKRYYGRILHYLK | 141 | P01574 | |
| KRRYFKLRGRTLYYA | 71 | Q16760 | |
| RALRYYYNKRILHKT | 96 | Q6ZN32 | |
| DYLHYIRKYNRFEKR | 91 | P62280 | |
| KYRYIPFTHGKRRYR | 171 | O15258 | |
| HRLRKEYLEYEKTRY | 961 | Q8NDX1 | |
| RKHFRALYNNLYRKY | 531 | Q9BX84 | |
| LVRAYVQRYRYFRKH | 1266 | Q9H7N4 | |
| LKKYHYSRRRSYEKG | 151 | Q70EL3 | |
| HSKTYLIRYQRKHDY | 446 | Q9NZV7 | |
| FRKHRNRVAYLSLYY | 176 | Q8TCI5 | |
| TKAALTIIRYYRRYK | 721 | O94832 | |
| YRRYKVKSYIHEVAR | 731 | O94832 |